Robert Simonson, DO
Emergency Medicine · Dallas, TXNPI 1407866056
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $21,600 of the $21,916 with a category attached, or 98.6%. Abiomed accounts for 99.1% of it on its own, with 6 other manufacturers making up the rest. 2024 is the largest year on record at $21,849, more than ten times the $13 reported in 2020. Among emergency medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 9 payments — averaging $2435.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$22K
- Abbott$109
- E.r. Squibb & Sons, L.L.C.$23
- Inari Medical, Inc.$16
- AstraZeneca$15
- Purdue Pharma L.p.$15
- plus $13 from 1 others
What the payments were for
- Speaking & faculty fees$21,60099%
- Food & beverage$3161%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 2 | $21,725 |
| Abbott | 2 | $109 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| Inari Medical, Inc. | 1 | $16 |
| AstraZeneca | 1 | $15 |
| Purdue Pharma L.p. | 1 | $15 |
| Mallinckrodt Hospital Products Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$21,725
How this compares
$21,916 in reported general payments places this provider in the 95th percentile of 3,952 emergency medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Etodolac | 24 | $338 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 14 | $169 |
| Meloxicam | 18 | $27 |
Paid to pharmacies, not to this prescriber.
Other emergency medicine in Dallas
- Farid DharamsiDallas$159K
- Gerald DelkDallas$60K
- Bradford BellardDallas$22K
- Betty YangDallas$21K
- James DetienneDallas$16K
- Deborah DiercksDallas$12K
- James LillyDallas$7K
- Kevin YavorcikDallas$6K
- John McKinneyTyler$1.9M
- William PeacockHouston$513K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.